Paper39620331
Effectiveness and Safety of Metformin, Teneligliptin, and Glimepiride Combination Therapy in Type 2 Diabetes: A Quasi Experimental Clinical Trial.
Manchi RK and 2 others. Curr Diabetes Rev, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness and Safety of Metformin, Teneligliptin, and Glimepiride Combination Therapy in Type 2 Diabetes: A Quasi Experimental Clinical Trial. Papers, record 39620331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39620331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effectiveness and Safety of Metformin, Teneligliptin, and Glimepiride Combination Therapy in Type 2 Diabetes: A Quasi Experimental Clinical Trial.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Sulfonylurea Compounds | Major topic |
| Metformin | Major topic |
| Hypoglycemic Agents | Major topic |
| Thiazolidines | Major topic |
| Pyrazoles | Major topic |
| Dipeptidyl-Peptidase IV Inhibitors | Major topic |
| Humans | |
| Male | |
| Female | |
| Drug Therapy, Combination | |
| Middle Aged | |
| Blood Glucose | |
| Glycated Hemoglobin | |
| Treatment Outcome | |
| Aged | |
| Adult | |
| Insulin Resistance | |
| Glycemic Control |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38524769 | Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38524769 | PubMed |
| 2 | 8039601 | Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. | Diabetes | 1994 | https://conductscience.org/library/papers/8039601 | PubMed |
| 3 | 25557969 | Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. | J Pediatr | 2015 | https://conductscience.org/library/papers/25557969 | PubMed |
| 4 | 22974359 | Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. | Curr Diabetes Rev | 2013 | https://conductscience.org/library/papers/22974359 | PubMed |
| 5 | 35898461 | Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35898461 | PubMed |
| 6 | 34708726 | Epidemiology of type 2 diabetes in India. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/34708726 | PubMed |
| 7 | 31862756 | 13. Children and Adolescents: Standards of Medical Care in Diabetes-2020. | Diabetes Care | 2020 | https://conductscience.org/library/papers/31862756 | PubMed |
| 8 | 34964831 | 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. | Diabetes Care | 2022 | https://conductscience.org/library/papers/34964831 | PubMed |
| 9 | 30291106 | Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Diabetes Care | 2018 | https://conductscience.org/library/papers/30291106 | PubMed |
| 10 | 27330726 | Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38). | J Diabetes Investig | 2016 | https://conductscience.org/library/papers/27330726 | PubMed |
| 11 | 34514991 | Rationality, Efficacy, Tolerability of Empagliflozin Plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials and Observational Studies. | Curr Diabetes Rev | 2022 | https://conductscience.org/library/papers/34514991 | PubMed |
| 12 | 17392540 | Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. | Diabetes Care | 2007 | https://conductscience.org/library/papers/17392540 | PubMed |
| 13 | 25295236 | Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis. | CMAJ Open | 2014 | https://conductscience.org/library/papers/25295236 | PubMed |
| 14 | 30121726 | Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis. | Diabetes Ther | 2018 | https://conductscience.org/library/papers/30121726 | PubMed |
| 15 | 22776014 | Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial. | Diabetes Obes Metab | 2012 | https://conductscience.org/library/papers/22776014 | PubMed |
| 16 | 31548957 | Effect of metformin on insulin levels, blood sugar, and body mass index in polycystic ovarian syndrome cases. | J Family Med Prim Care | 2019 | https://conductscience.org/library/papers/31548957 | PubMed |
| 17 | 16599037 | Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome. | J Ayub Med Coll Abbottabad | 2005 | https://conductscience.org/library/papers/16599037 | PubMed |
| 18 | 28484968 | A Practical Review of C-Peptide Testing in Diabetes. | Diabetes Ther | 2017 | https://conductscience.org/library/papers/28484968 | PubMed |
| 19 | 30591792 | Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals. | Saudi J Biol Sci | 2018 | https://conductscience.org/library/papers/30591792 | PubMed |
| 20 | 21537412 | Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients. | Diabetes Metab J | 2011 | https://conductscience.org/library/papers/21537412 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39620331
GET https://conductscience.org/api/papers/v1/39620331/references?page=2